Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis

Chest

Volumn 121, Issue 6, 2002, Pages 1754-1760

  Graff, Gavin R ^a   Burns, Jane L ^b  

^a University of Missouri   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Cystic fibrosis; Quinolone; Stenotrophomonas maltophilia; Steroids; Tobramycin

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; PENICILLIN G; SULFONAMIDE; TOBRAMYCIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; HUMAN; INCIDENCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; STENOTROPHOMONAS MALTOPHILIA;

EID: 0036282322     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.6.1754     Document Type: Article

References (19)

1. Microbiology of airway disease in patients with cystic fibrosis
2. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis
3. Stenotrophomonas maltophilia in cystic fibrosis: Incidence and prevalence
4. Bacterial colonization with Xanthomonas maltophilia: A retrospective study in a cystic fibrosis patient population
5. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients
6. Acquiring Stenotrophomonas maltophilia does not decrease survival in patients with cystic fibrosis
7. Microbiology of sputum from patients at cystic fibrosis centers in the United States
8. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis
9. Stenotrophomonas maltophilia in cystic fibrosis patients
10. Nosocomial infection caused by Xanthomonas maltophilia: A case-control study of predisposing factors
11. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia
12. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
13. Standardization of spirometry: A summary of recommendations from the American Thoracic Society (the 1987 update)
14. Changes in the normal maximal expiratory flow-volume curve with growth and aging
15. Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998
16. Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR
17. Use of random amplified polymorphic DNA PCR to examine the epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis
18. Pseudomonas aeruginosa corneal ulcer isolates distinguished using the arbitrarily primed PCR DNA fingerprinting method